Lincoln National Corp Has $4.46 Million Position in UnitedHealth Group Incorporated (NYSE:UNH)

Lincoln National Corp lessened its position in UnitedHealth Group Incorporated (NYSE:UNHGet Rating) by 2.2% in the 1st quarter, Holdings Channel reports. The firm owned 8,750 shares of the healthcare conglomerate’s stock after selling 201 shares during the period. Lincoln National Corp’s holdings in UnitedHealth Group were worth $4,462,000 at the end of the most recent quarter.

Several other large investors have also recently bought and sold shares of UNH. Norges Bank bought a new stake in shares of UnitedHealth Group during the fourth quarter worth $4,478,185,000. State Street Corp grew its position in UnitedHealth Group by 1.9% in the fourth quarter. State Street Corp now owns 45,559,868 shares of the healthcare conglomerate’s stock valued at $22,877,432,000 after purchasing an additional 869,827 shares in the last quarter. Marshall Wace LLP grew its position in UnitedHealth Group by 2,853.0% in the fourth quarter. Marshall Wace LLP now owns 861,798 shares of the healthcare conglomerate’s stock valued at $432,746,000 after purchasing an additional 832,614 shares in the last quarter. Capital International Investors grew its position in UnitedHealth Group by 4.3% in the fourth quarter. Capital International Investors now owns 19,342,468 shares of the healthcare conglomerate’s stock valued at $9,713,058,000 after purchasing an additional 790,219 shares in the last quarter. Finally, DZ BANK AG Deutsche Zentral Genossenschafts Bank Frankfurt am Main grew its position in UnitedHealth Group by 41.0% in the fourth quarter. DZ BANK AG Deutsche Zentral Genossenschafts Bank Frankfurt am Main now owns 2,037,257 shares of the healthcare conglomerate’s stock valued at $1,027,849,000 after purchasing an additional 592,648 shares in the last quarter. Institutional investors own 87.48% of the company’s stock.

UnitedHealth Group Stock Up 0.2 %

Shares of NYSE UNH opened at $535.06 on Friday. UnitedHealth Group Incorporated has a one year low of $383.12 and a one year high of $553.29. The company has a debt-to-equity ratio of 0.60, a current ratio of 0.77 and a quick ratio of 0.78. The firm’s 50 day simple moving average is $506.46 and its two-hundred day simple moving average is $499.44. The stock has a market capitalization of $500.48 billion, a P/E ratio of 27.94, a PEG ratio of 1.65 and a beta of 0.76.

UnitedHealth Group (NYSE:UNHGet Rating) last issued its quarterly earnings results on Friday, July 15th. The healthcare conglomerate reported $5.57 EPS for the quarter, beating analysts’ consensus estimates of $5.24 by $0.33. UnitedHealth Group had a net margin of 5.95% and a return on equity of 25.45%. The business had revenue of $80.33 billion for the quarter, compared to analysts’ expectations of $79.68 billion. During the same period last year, the business earned $4.70 earnings per share. The business’s quarterly revenue was up 12.6% on a year-over-year basis. As a group, analysts expect that UnitedHealth Group Incorporated will post 21.86 EPS for the current fiscal year.

UnitedHealth Group Increases Dividend

The company also recently announced a quarterly dividend, which was paid on Tuesday, June 28th. Stockholders of record on Monday, June 20th were issued a $1.65 dividend. This is a boost from UnitedHealth Group’s previous quarterly dividend of $1.45. The ex-dividend date of this dividend was Thursday, June 16th. This represents a $6.60 annualized dividend and a dividend yield of 1.23%. UnitedHealth Group’s dividend payout ratio (DPR) is currently 34.46%.

Wall Street Analyst Weigh In

A number of research analysts recently weighed in on UNH shares. Cowen raised their target price on shares of UnitedHealth Group from $512.00 to $596.00 in a research report on Monday, April 18th. Oppenheimer increased their price target on shares of UnitedHealth Group from $600.00 to $610.00 and gave the company an “outperform” rating in a research note on Monday, July 18th. Cowen increased their price target on shares of UnitedHealth Group from $512.00 to $596.00 in a research note on Monday, April 18th. Royal Bank of Canada set a $563.00 target price on shares of UnitedHealth Group and gave the stock an “outperform” rating in a research note on Monday, April 18th. Finally, Deutsche Bank Aktiengesellschaft raised their price target on shares of UnitedHealth Group from $549.00 to $556.00 in a research report on Tuesday, July 19th. Three research analysts have rated the stock with a hold rating, sixteen have given a buy rating and two have issued a strong buy rating to the company. According to MarketBeat.com, UnitedHealth Group has a consensus rating of “Moderate Buy” and a consensus price target of $582.50.

Insider Transactions at UnitedHealth Group

In related news, Director Richard T. Burke sold 2,500 shares of the firm’s stock in a transaction on Thursday, May 19th. The stock was sold at an average price of $478.96, for a total value of $1,197,400.00. Following the completion of the sale, the director now owns 1,215,000 shares of the company’s stock, valued at $581,936,400. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. In other UnitedHealth Group news, CEO Andrew Witty sold 11,376 shares of the firm’s stock in a transaction on Monday, July 18th. The stock was sold at an average price of $527.90, for a total transaction of $6,005,390.40. Following the completion of the transaction, the chief executive officer now owns 76,559 shares of the company’s stock, valued at $40,415,496.10. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this link. Also, Director Richard T. Burke sold 2,500 shares of the firm’s stock in a transaction on Thursday, May 19th. The shares were sold at an average price of $478.96, for a total value of $1,197,400.00. Following the transaction, the director now directly owns 1,215,000 shares of the company’s stock, valued at approximately $581,936,400. The disclosure for this sale can be found here. Over the last 90 days, insiders have sold 130,144 shares of company stock worth $69,269,555. Insiders own 0.40% of the company’s stock.

UnitedHealth Group Company Profile

(Get Rating)

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. It operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage and well-being services to individuals age 50 and older addressing their needs for preventive and acute health care services, as well as services dealing with chronic disease and other specialized issues for older individuals; Medicaid plans, children's health insurance and health care programs; health and dental benefits; and hospital and clinical services.

See Also

Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Incorporated (NYSE:UNHGet Rating).

Institutional Ownership by Quarter for UnitedHealth Group (NYSE:UNH)

Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.